[KBTS Glioma Academy]
Redefining Standards in Glioma: Entering the Era of Molecular-Driven Care
좌장: 강신혁 (대한뇌종양학회 회장)
16:00-16:15
Targeting IDH-mutant gliomas with vorasidenib: Advancing precision neuro-oncology
김경민 (인하대)
16:15-16:30
Evidence-based outcomes and real-world clinical impact—What lies ahead?
강호 (서울대)
16:30-16:45
Beyond the tumor mass: From initiating clones to overt isocitrate dehydrogenase-mutant gliomas
강석구 (연세대)
16:45-17:00
Discussion / Q&A
17:00-17:30
2026 운영위원회
17:30-18:00
Welcome Reception
18:00-20:00
전야제 행사
Copyright(C) The Korean Brain Tumor Society. All Rights Reserved.
서울 서초구 서초동 1678-2번지 동아빌라트 2타운 407호
Tel) 02-523-6811 Fax) 02-523-6812 E-mail) koreabraintumor@gmail.com